ClinicalTrials.gg
Enrolling by invitationNCT06501859Updated Jun 5, 2026

Rehabilitation With the Shoulder Pacemaker

An interventional study of Standard of care physical therapy and Shoulder pacemaker with physical therapy in Shoulder Injuries, sponsored by University of Utah. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by University of Utah · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Aug 2023, registered Jul 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 39 studies in Shoulder Injuries with a site in United States — 14 open to participants now, 18 under way, none of them phase 3. Shoulder Injuries · United States.

Planned enrollment
6th of 26
100 · median 64
Started
2023
with 5 others
No phase
20 of 39
7 open now
Primary completion
2027-07
later than 8 of 17 live
Registered
34th of 39
by date

Among the 39 studies in Shoulder Injuries with a site in United States, this one is the 6th largest by planned enrollment of the 26 interventional ones that give a count, is one of 6 that started in 2023, is one of 20 with no phase, reaches primary completion later than 8 of the 17 other live ones, and was the 34th registered.

Shoulder Injuries

118 studies on the registry are indexed under Shoulder Injuries; 32 are open to participants now.

Browse Shoulder Injuries studies →

Open to participants now

14 of the 39 studies in Shoulder Injuries with a site in United States are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 17 Shoulder Injuries studies recruiting now, 8 (47%) set no upper age limit and 6 (35%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 39 studies in Shoulder Injuries with a site in United States, or all of them as a file.
02

Study summary

The investigators purpose of the proposed study is to use the FDA approved Shoulder Pacemaker device in patients undergoing reverse shoulder arthroplasty and study the functional outcomes compared to a standard post-operative rehabilitation program. The investigators hypothesize that use of the Shoulder Pacemaker reduce pain and will allow for improved range of motion and function in patients undergoing RSA. The findings of this research may very well improve function in RSA patients through a novel, non-invasive approach.

Read the detailed description

The reverse shoulder arthroplasty (RSA) has increased utility in recent years for shoulder conditions such as rotator cuff tear arthropathy, massive irreparable rotator cuff tears, severe glenohumeral arthritis, proximal humerus fracture, and failed shoulder arthroplasty. While RSA may commonly be the only surgical treatment for some of these conditions, the outcomes and adverse event profiles are significant. Specifically, RSA patients often complain of poor range of motion and function with the arm above the head. Despite many attempts at solving these shortcomings with new implant design iterations and improved implant positioning, these continue to be a source of frustration with patients and surgeons alike.

Poor scapulothoracic motion is associated with poor shoulder range of motion, especially after RSA. Past investigators have shown that in certain RSA patients, there is a near complete loss of glenohumeral motion and forward elevation and abduction is highly dependent on scapulothoracic motion. In a separate study, In addition, these investigators demonstrated that internal rotation after RSA is largely dependent on scapulothoracic motion. Several years ago, a device called the Shoulder Pacemaker (Alyve Medical, Denver, CO) was developed initially for the treatment of functional instability in the setting of scapular dyskinesis. It functions as a wearable muscle electrostimulator that allows for periscapular muscle stimulation as well as feedback on shoulder range of motion. The motion technology recognizes muscle movement and automatically sets the appropriate stimulation intensity according to the movement. This improves scapular muscle recruitment during range of motion. While the data is limited, there has been some early promising results for this pathology. As function after RSA is particularly reliant on scapulothoracic function, the current investigators may infer that use of the Shoulder Pacemaker device may function well in patients with reverse shoulder replacements. Specifically, the device would allow patients to train their periscapular musculature after RSA to improve global shoulder motion and function. To the current investigators knowledge, there is no current research on the use of the Shoulder Pacemaker after RSA.

03

Conditions studied

  • Shoulder Injuries

Keywords

  • Reverse Shoulder Arthroplasty (RSA)
  • Shoulder Pacemaker
  • Rehabilitation
  • Range of motion
  • Pain
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients indicated for primary reverse shoulder arthroplasty
  • Surgery at University of Utah Facilities
  • Patients between the ages 18-80.

Exclusion criteria

Exclusion Criteria:

  • Prior ipsilateral shoulder arthroplasty
  • Inability or unwillingness to participate in the rehabilitation protocol
  • Prior cardiac pacemaker or spinal cord stimulator
  • Age over 80
  • History of periscapular surgery
  • History of ipsilateral neurologic injury
  • Prisoners
  • Patients requiring prolonged immobilization deviating from standard protocol
  • Patients who have an implantable medical device or other electrical device.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Standard of care physical therapy

    Control group and will not use the shoulder pacemaker, but will participate in a standardized physical therapy protocol for 3 months.

    Other: Standard of care physical therapy

  • Experimental
    Shoulder pacemaker with physical therapy

    Include a standardized physical therapy protocol with utilization of the Shoulder Pacemaker device 3 times per week over a 3-month period starting at 6 weeks post-operatively.

    Device: Shoulder pacemaker with physical therapy

Interventions

  • OtherStandard of care physical therapy

    Standard rehabilitation protocol for 3 months.

  • DeviceShoulder pacemaker with physical therapy

    Standardized rehabilitation protocol with utilization of the shoulder pacemaker device 3 times per week over a 3-month period.

06

What researchers measure

Primary outcomes

  1. American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    Time frame: Pre-operatively

  2. American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    Time frame: 6 weeks after surgery

  3. American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    Time frame: 3 months after surgery

  4. American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    Time frame: 6 months after surgery

  5. American Shoulder and Elbow Surgeons score

    Shoulder specific scoring system out of 100. A patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

    Time frame: 1 year after surgery

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2023 (actual). Primary completion is estimated for Jul 2027, 47 months after the start.

Of 38 non-industry interventional studies with no phase under Shoulder Injuries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 45. This study's planned 47 months is above that.

Counting every sponsor, half of 43 studies reached it within 15 months; a quarter within 7 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2024
First posted
Jul 15, 2024
StartActual
Aug 2, 2023
Primary completionEst.
Jul 2027
CompletionEst.
Jul 2027
Last update
Jun 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06501859
Lead sponsor
University of Utah
Responsible party
Christopher Joyce (Principle Investigator, University of Utah) — Principal investigator
First posted
Jul 15, 2024
Start date
Aug 2, 2023
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Jun 5, 2026

Study contacts

Christopher Joyce, M.D.
principal investigator · University of Utah Orthopaedics

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion